Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Berg

Showing results (561-570 of 633) with videos related to

Pageof 64
Sort By:
Gastroenterology|January 12, 2010
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association studyAndri Rauch, Zoltán Kutalik, Patrick Descombes, et al.
Journal of Cachexia, Sarcopenia and Muscle|August 18, 2023
Prognostic role of radiomics-based body composition analysis for the 1-year survival for hepatocellular carcinoma patientsSylvia Saalfeld, Robert Kreher, Georg Hille, et al.
JHEP Reports : Innovation in Hepatology|May 27, 2021
Predictive performance of newer Asian hepatocellular carcinoma risk scores in treated Caucasians with chronic hepatitis BGeorge V Papatheodoridis, George N Dalekos, Ramazan Idilman, et al.
Gastroenterology|February 9, 2013
Increased T-helper 2 cytokines in bile from patients with IgG4-related cholangitis disrupt the tight junction-associated biliary epithelial cell barrierTobias Müller, Claudia Beutler, Almudena Hurtado Picó, et al.
The American Journal of Gastroenterology|March 15, 2018
Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosisFelix Stickel, Stephan Buch, Hans Dieter Nischalke, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 14, 2020
Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE)Milan J Sonneveld, Jun Yong Park, Apichat Kaewdech, et al.
Hepatology Communications|May 23, 2023
Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trialAlexey Surov, Maximilian Thormann, Mattes Hinnerichs, et al.
JHEP Reports : Innovation in Hepatology|February 18, 2026
Soluble urokinase plasminogen activator receptor is a prognostic biomarker in decompensated cirrhosisSven Lamatsch, Mohsin Hassan, Kai Kappert, et al.
Hepatology (Baltimore, Md.)|June 17, 2017
The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis BGeorge V Papatheodoridis, Ramazan Idilman, George N Dalekos, et al.
Journal of Hepatology|January 26, 2020
Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis BGeorge V Papatheodoridis, Vana Sypsa, George N Dalekos, et al.
Pageof 64

Showing results (561-570 of 633) with videos related to

Sort By:
Pageof 64
Gastroenterology|January 12, 2010
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association studyAndri Rauch, Zoltán Kutalik, Patrick Descombes, et al.
Journal of Cachexia, Sarcopenia and Muscle|August 18, 2023
Prognostic role of radiomics-based body composition analysis for the 1-year survival for hepatocellular carcinoma patientsSylvia Saalfeld, Robert Kreher, Georg Hille, et al.
JHEP Reports : Innovation in Hepatology|May 27, 2021
Predictive performance of newer Asian hepatocellular carcinoma risk scores in treated Caucasians with chronic hepatitis BGeorge V Papatheodoridis, George N Dalekos, Ramazan Idilman, et al.
Gastroenterology|February 9, 2013
Increased T-helper 2 cytokines in bile from patients with IgG4-related cholangitis disrupt the tight junction-associated biliary epithelial cell barrierTobias Müller, Claudia Beutler, Almudena Hurtado Picó, et al.
The American Journal of Gastroenterology|March 15, 2018
Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosisFelix Stickel, Stephan Buch, Hans Dieter Nischalke, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 14, 2020
Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE)Milan J Sonneveld, Jun Yong Park, Apichat Kaewdech, et al.
Hepatology Communications|May 23, 2023
Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trialAlexey Surov, Maximilian Thormann, Mattes Hinnerichs, et al.
JHEP Reports : Innovation in Hepatology|February 18, 2026
Soluble urokinase plasminogen activator receptor is a prognostic biomarker in decompensated cirrhosisSven Lamatsch, Mohsin Hassan, Kai Kappert, et al.
Hepatology (Baltimore, Md.)|June 17, 2017
The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis BGeorge V Papatheodoridis, Ramazan Idilman, George N Dalekos, et al.
Journal of Hepatology|January 26, 2020
Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis BGeorge V Papatheodoridis, Vana Sypsa, George N Dalekos, et al.
Pageof 64